Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tesaro's ovarian cancer drug Zejula added to Cancer Drugs Fund

pharmatimesJuly 12, 2018

Tag: recurrent ovarian cancer

PharmaSources Customer Service